Fortis Healthcare Limited
FORTIS
Rangering i aksjer
#3027
Established in 1996 and headquartered in Gurugram, India, Fortis Healthcare... Established in 1996 and headquartered in Gurugram, India, Fortis Healthcare Limited operates as an integrated provider of healthcare services. The company extends its offerings, which encompass secondary, tertiary, and quaternary medical care, across India, the United Arab Emirates, Sri Lanka, and other international markets. Its diverse healthcare infrastructure includes a network of hospitals, diagnostic facilities, and specialized day-care centers. Fortis delivers expertise across a broad spectrum of medical disciplines, including cardiology, cosmetic and dental sciences, dermatology, endocrinology, emergency medicine, ENT, fetal medicine, gastroenterology and hepatology, general surgery, haematology, infertility treatment, internal medicine, mental and behavioral health, nephrology, neurosurgery, neurointervention, neurology, obstetrics and gynaecology, oncology, ophthalmology, orthopedics, pediatrics, physiotherapy, plastic surgery, pulmonology, radiology, rheumatology, thoracic surgery, transplant medicine, urology, and numerous other supporting specialties. By March 31, 2022, the company managed 26 hospitals, housing approximately 4,300 operational beds, in addition to around 426 diagnostic centers and laboratories, complemented by 2,550 collection centers.
Aksjekurs
$8.00
Markedsverdi
$6.04B
Endring (1 dag)
-1.73%
Endring (1 år)
-35.85%
Land
IN
Handel Fortis Healthcare Limited (FORTIS)
Kategori
Healthcare
Antall utestående aksjer for Fortis Healthcare Limited (FORTIS)
Antall utestående aksjer per June 2026: 754.96M
Ifølge Fortis Healthcare Limited sine siste økonomiske rapporter og aksjekurs er antall utestående aksjer nå 754.96M. Ved slutten av March 2024 hadde selskapet 754.96M utestående aksjer. Antallet utestående aksjer påvirkes vanligvis av aksjesplitt og tilbakekjøp.
Historikk over utestående aksjer for Fortis Healthcare Limited (FORTIS) fra 2002 til 2026
Utestående aksjer ved utgangen av hvert år
| År | Utestående aksjer | Endre |
|---|---|---|
| 2026 (TTM) | 754.96M | 0.05% |
| 2025 | 754.59M | -0.05% |
| 2024 | 754.96M | 0.00% |
| 2023 | 754.96M | 0.00% |
| 2022 | 754.96M | 0.00% |
| 2021 | 754.96M | 0.00% |
| 2020 | 754.96M | 17.23% |
| 2019 | 644.02M | 0.00% |
| 2018 | 644.02M | 0.00% |
| 2017 | 644.02M | 0.00% |
| 2016 | 644.02M | 0.00% |
| 2015 | 644.02M | 0.00% |
| 2014 | 644.02M | 0.00% |
| 2013 | 644.02M | 0.00% |
| 2012 | 644.02M | 0.00% |
| 2011 | 644.02M | 0.00% |
| 2010 | 644.02M | 0.00% |
| 2009 | 644.02M | 0.00% |
| 2008 | 644.02M | 0.00% |
| 2007 | 644.02M | 0.00% |
| 2006 | 644.02M | 0.00% |
| 2005 | 644.02M | 0.00% |
| 2004 | 644.02M | 0.00% |
| 2003 | 644.02M | 0.00% |
| 2002 | 644.02M | 0.00% |
Utestående aksjer for lignende selskaper eller konkurrenter
| Selskap | Utestående aksjer | Forskjell | Land |
|---|---|---|---|
| 222.83M | -70.48% |
US
|
|
| - | - |
DE
|
|
| 83.52M | -88.94% |
US
|
|
| 350.00M | -53.64% |
SA
|
|
| 2.18B | 188.79% |
BR
|
